Covid-19 vaccines

    • Covid-19 vaccine makers slump on expected patent waiver

      Covid-19 vaccine makers slump on expected patent waiver

      The stocks of all companies involved in production of Covid-19 vaccines fell, as US and EU backed the call from the World Health Organisation to waive patent rights claims over the jabs production, Reuters reported. The share slumps came even as some analysts raised doubts about any near-term pressure on Covid-19 vaccine sales from discussions of waiving intellectual property rights, given the manufacturing complexity and scarcity of raw materials. Combined, Pfizer and Moderna have forecast a total of over $45 billion in sales this year for their Covid-19 vaccines.

      37
    • US backs WTO calls to grant vaccine know-how to poor countries

      US backs WTO calls to grant vaccine know-how to poor countries

      The US showed a rare shift in its policy related to defense of intellectual rights over the Covid-19 vaccines, BBC reported. In a move which was considered surprising by many, the administration of the White House backed calls from many organizations including the WTO to grant know-how rights and patents related to production of vaccines to poor countries in a bid to boost the output and the rollout of jabs.

      39